the therapeutic implications of shared pathophysiology in classical itp and other thrombocytopenias
Published 5 months ago • 35 plays • Length 3:11Download video MP4
Download video MP3
Similar videos
-
1:53:59
the pathophysiology of itp and novel therapies
-
1:59
novel investigational drugs and promising therapies for immune thrombocytopenia
-
1:32
shifting the treatment landscape of itp: novel agents and future outlooks
-
0:52
the role and clinical use of tpo receptor agonists in the treatment of itp
-
1:53
immune thrombocytopenic purpura (itp) - causes, pathogenesis, signs & symptoms, diagnosis, treatment
-
17:52
immune thrombocytopenia (itp) | idiopathic thrombocytopenic purpura [updated 2024]
-
3:23
session overview: improving treatment for patients with itp
-
3:55
the association between itp and multiple myeloma
-
1:54
fostamatinib and efgartigimod: novel agents in the treatment of itp
-
1:24
recent advances in the treatment and management of itp
-
1:55
latest updates in the management of immune thrombocytopenia
-
1:53
avatrombopag: a novel oral therapy for the treatment of itp
-
2:03
unmet needs in immune thrombocytopenia
-
3:26
the risk of thrombotic events in patients with mgus: an analysis from the istopmm trial
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
1:40
new therapeutic approaches targeting xpo1-overexpression in tp53-mutated myeloid malignancies
-
7:51
testimony thursday - i was healed of a disease with no cure (itp)
-
20:11
behind the mystery of chronic immune thrombocytopenia (itp): a blood platelet disorder
-
11:48
initiating coverage: iovance biotherapeutics & their tumor-infiltrating lymphocytes (tils) platform
-
19:42
immune thrombocytopenia (itp) — most comprehensive explanation — hematology
-
3:17
thrombopoietin receptor agonists in itp: current status and future outlooks
-
2:38
the management of itp during and after the covid-19 pandemic